Janet L. Dally has more than 20-years of experience in the biotechnology, pharmaceutical and medical technology industries as an investor relations advisor, healthcare fund analyst, business development and medical device marketing management, and microbiologist.
Before joining MD Becker Partners, she was President of MontRidge, LLC, a boutique investor relations and strategic consulting firm specializing in the life science industry. She first joined MontRidge as Vice President in 1998. During her tenure at MontRidge, Ms. Dally built meaningful relationships with the executive management of life science clients and the US and European investment community resulting in increased institutional ownership, diversified shareholder base, sell-side analyst coverage, enhanced valuation and successful financing.
Prior to joining MontRidge, Ms. Dally was Vice President of Investor Relations at Burns McClellan, a life sciences communication firm. She also has pharmaceutical industry experience at both Sterling Drug and Forest Laboratories where she held management positions in strategic planning, business development, licensing and M&A.
Ms. Dally has 6-years of experience as an analyst evaluating and recommending biotechnology, pharmaceutical, medical device and healthcare services firms for the Merrill Lynch Healthcare Fund.
She acquired a B.S. in Medical Technology from Rutgers University, M.S. in Microbiology from Wagner College and an M.B.A. from the Tepper School of Business, Carnegie Mellon University.